C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2002
12/26/2002	US20020198254 Bactericides, fungicides and parasticides
12/26/2002	US20020198250 Pyrrolidine derivative hair growth compositions and uses
12/26/2002	US20020198239 Oxidizing 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl)thio)-1H -benzimidazole into S-omeprazole in an organic solvent, convering formed S-omeprazole into corresponding potassium salt by treating with potassium source
12/26/2002	US20020198237 2,5-substituted imidazole compounds useful as histamine H3 receptor mediators
12/26/2002	US20020198232 4-substituted quinoline derivatives
12/26/2002	US20020198219 2-pyridinamine compositions and related methods
12/26/2002	US20020198216 Novel farnesyl protein transferase inhibitors as antitumor agents
12/26/2002	US20020198214 Such as (3-(4-(4-fluoro-benzyl)-piperidine-1-carbonyl)-4-methoxy-phenyl)-oxo-acetic acid methyl ester for proinflammation response in multiple sclerosis, inflammatory bowel disease, osteoarthritis, and other arthritic conditions
12/26/2002	US20020198213 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
12/26/2002	US20020198206 Such as 1-Cyclohexyl-4-(4-fluorophenyl)-5-((2-phenylamino)pyrimidin-4-yl)imidazole; for use as cytokine inhibitors
12/26/2002	US20020198204 Certain fused pyrrolecarboxamides; a new class of GABA brain receptor
12/26/2002	US20020198199 Such as 2-(2-(N-((4-aminoiminomethylphenyl)methyl)-3-(3-aminophenyl)-6-(N,N -dimethylhydrazino)-1-oxypyridinyl))acetami de which inhibit serine proteases for preventing and treating thrombotis
12/26/2002	US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
12/26/2002	US20020198197 Metabotropic glutamate receptor agonist for treatment or prevention of acute and/or chronic neurological disorders
12/26/2002	US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
12/26/2002	US20020198194 Neuropeptide Y (NPY) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity
12/26/2002	US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
12/25/2002	CN1387531A Pyrazolo [4,3-d] pyrimidine derivs.
12/25/2002	CN1387528A Heterocyclic substd, pyrazolones
12/25/2002	CN1387527A Qinazoline derivs. as VEGF inhibitors
12/25/2002	CN1387526A Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
12/25/2002	CN1387517A 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions contg. them
12/25/2002	CN1387516A Substd. 5-benzyl-2,4-diaminopyrimidines
12/25/2002	CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
12/25/2002	CN1097052C Process for production of amidinoindole derivs, and salts thereof
12/25/2002	CN1097051C N-heteroaryl-pyridinesulfonamide derivs. and their use as endotheliin antagonists
12/25/2002	CN1097050C Substd 2,4-imidazolidinedione compounds and pharmaceutical active ingredients
12/24/2002	US6498255 Cholinesterase inhibitors; cognition activators; alzheimer's disease; e.g., 3-(2-(1-(phenylmethyl)-4-piperidinyl)ethyl)-1,2-benzisoxazole
12/24/2002	US6498254 Antiretroviral compounds and compositions
12/24/2002	US6498251 Tetrahydrobenzindole derivatives
12/24/2002	US6498185 Enzyme factor xa inhibitors
12/24/2002	US6498176 Inhibiting tumor growth via inhibition of tumor-related angiogenesis
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002	US6498170 4-((2s)-3-(1-(4-butoxy-benzenesulfonyl)-azetidin-3-ylamino)-2 -hydroxy- propoxy)-phenol for example; hypoglycemic agent; increasing lean meat to fat ratio in mammals
12/24/2002	US6498169 Cyclic amine compounds and pharmaceutical composition containing the same
12/24/2002	US6498168 Muscarinic antagonists
12/24/2002	US6498167 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/24/2002	US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis
12/24/2002	US6498161 Treating infection by hiv; delaying of the onset of aids; asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis
12/24/2002	US6498160 For therapy of emphysema, chronic bronchitis, asthma and allergic rhinitis
12/24/2002	US6498159 Such as 4-((3-chloro-4-methoxybenzyl)amino)-1-((4-hydroxy-4 -hydroxymethyl)piperidino)-6-phthalazine carbonitrile
12/24/2002	US6498156 Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use
12/24/2002	US6498125 Pyridine ketones useful as herbicides
12/24/2002	US6497886 1,3-bis-(N-lactamyl) propane and the pharmaceutical and cosmetic use thereof
12/24/2002	CA2252039C Isatin derivatives as acetylcholinesterase inhibitors and analgesics
12/24/2002	CA2214744C 3-(bis-substituted phenylmethylene)oxindole derivatives
12/24/2002	CA2150812C Catechol diethers as selective pde iv inhibitors
12/24/2002	CA2054339C 3-amidoindolyl derivatives
12/19/2002	WO2002101073A2 Aryl-benzimidazole compounds having antiinfective activity
12/19/2002	WO2002101007A2 Antipathogenic benzamide compounds
12/19/2002	WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
12/19/2002	WO2002100861A1 1-(3-phenyloxypropyl)piperidine derivatives
12/19/2002	WO2002100860A2 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
12/19/2002	WO2002100853A1 Pyrazole derivatives as hiv reverse transcriptase inhibitors
12/19/2002	WO2002100852A1 Benzothiophene compounds having antiinfective activity
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100847A2 Factor xa inhibitor
12/19/2002	WO2002100838A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	WO2002100835A1 Heterocyclic compounds having antitumor activity
12/19/2002	WO2002100833A1 Rho KINASE INHIBITORS
12/19/2002	WO2002100832A1 Isoquinoline compounds having antiinfective activity
12/19/2002	WO2002100825A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances
12/19/2002	WO2002100410A1 Methods of treating alzheimer's disease
12/19/2002	WO2002100405A1 Isoquinoline inhibitors of p38
12/19/2002	WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	WO2002100401A1 Soluble cdk-inhibitory indirubin derivatives
12/19/2002	WO2002100368A1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye
12/19/2002	WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002	WO2002085853A3 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/19/2002	WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
12/19/2002	WO2002070541A3 Peptide deformylase inhibitors
12/19/2002	WO2002070515A3 Chromane derivatives, process for their preparation and their use as antitumor agents
12/19/2002	WO2002069972A3 Triazole compounds and the use thereof in the prophylaxis and therapy of neurodegenerative diseases, cerebral trauma and cerebral ischemia
12/19/2002	WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002	WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
12/19/2002	WO2000058303A9 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
12/19/2002	US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
12/19/2002	US20020193605 Selectively inhibits action of N-type calcium channel; treatment of ischemic cerebrovascular disorders caused by cerebral infarction or intracerebral bleeding, Alzheimer's disease, AIDS related dementia, Parkinson's disease
12/19/2002	US20020193599 Dihydropyridines and new uses thereof
12/19/2002	US20020193597 3-(heteroarylamino) indazole, 1,2-benzisothiazole, or 1,2-benzisoxazole derivatives of given formula; for treating nervous system disorders such as pain, anxiety and bipolar disorder
12/19/2002	US20020193596 Inhibitors of protein isoprenyl transferases
12/19/2002	US20020193595 Agonists of the melanocortin-4 receptor ("MC-4r"); useful treating obesity and type 2 diabetes
12/19/2002	US20020193541 Thermosetting resin compositions containing maleimide and/or vinyl compounds
12/19/2002	US20020193420 Neurotrophic, low molecular weight, small molecule heterocyclic ketone or thioester compounds are nonimmunosuppressive, has an affinity for FKBP type immunophilins
12/19/2002	US20020193407 Modulators of CCR5 chemokine receptor activity
12/19/2002	US20020193399 N-arylsulfonyl aryl aza-bicyclic derivatives as potent cell adhesion inhibitors
12/19/2002	US20020193398 For therapy and prophylaxis of blood coagulation and cardiovascular disorders
12/19/2002	US20020193390 Pharmaceutical compositions containing an N-(substituted glycyl)-2- cyanopyrrolidine and at least one other antidiabetic agent and their use in inhibiting dipeptidyl peptidase-IV
12/19/2002	US20020193387 As antimalarial agent
12/19/2002	US20020193382 Sulfonamide derivatives, their production and use
12/19/2002	US20020193377 Quinazolines as MMP-13 inhibitors
12/19/2002	US20020193375 Heterocyclic derivatives which inhibit factor Xa
12/19/2002	US20020193367 Dihydro-benzo [b] [1,4] diazepin-2-one derivatives
12/19/2002	DE10128331A1 New 2-(heteroarylsulfonyl-amino)-benzamide derivatives, which are potassium ion channel blocking antiarrhythmic agents, useful for e.g. treating atrial fibrillation or flutter
12/19/2002	CA2450628A1 Benzothiophene compounds having antiinfective activity
12/19/2002	CA2450625A1 Isoquinoline compounds having antiinfective activity
12/19/2002	CA2450262A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	CA2449948A1 Methods of treating alzheimer's disease
12/19/2002	CA2448552A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/18/2002	EP1267369A2 Pyridine compound, its use as charge transfer material, and photoelectrochemical cell

1 ... 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 ... 1080